Application of PainDETECT in pediatric chronic pain: how well does it identify neuropathic pain and its characteristics?

• Published in: Pain reports 2023-12, Vol.8 (6), p.e1109-e1109
• Main Authors: Hess, Courtney W, Van Orden, Amanda R, Mesaroli, Giulia, Stinson, Jennifer N, Borsook, David, Simons, Laura E
• Format: Article
• Language: English
• Subjects: Pediatric
• ISSN: 2471-2531; 2471-2531
• DOI: 10.1097/PR9.0000000000001109

Neuropathic pain (NP) arises from nerve damage or disease, and when not defined, it can impair function and quality of life. Early detection allows for interventions that can enhance outcomes. Diagnosis of NP can be difficult if not properly evaluated. PainDETECT is a NP screening tool developed and successfully used in adults. We evaluated the validity of painDETECT in a pediatric population. Adolescents and young adults (10-19 years old) completed painDETECT and quantitative sensory testing (QST), which assessed mechanical allodynia and hyperalgesia, common symptoms of NP. Pain diagnoses, including neuropathic pain (n = 10), were collected through documentation in the medical chart. Descriptive statistics were used to examine age, gender, pain diagnoses, and painDETECT scores. Kruskal-Wallis H tests were conducted to examine differences in QST results across painDETECT categorizations. Youth with chronic pain (N = 110, M = 15.08 ± 2.4 years, N = 88) and peers without pain (N = 55, M = 15.84 ± 3.9 years, N = 39) completed the painDETECT. The painDETECT scores for youth with pain (M = 12.7 ± 6.76) were significantly higher than those for peers without pain (M = 2.05 ± 2.41). PainDETECT demonstrated 80% sensitivity and 33% specificity in a pediatric population. Individuals who screened positively on the PainDETECT had significantly higher mechanical allodynia (M = 0.640 ± 0.994) compared with those who screened negatively (M = 0.186 ± 0.499; = 0.016). PainDETECT demonstrated the ability to screen for NP, and QST mechanical allodynia results were consistent with a positive NP screen. Results of the study offer preliminary support for the ongoing assessment of the painDETECT as a brief, inexpensive, and simple-to-use screening tool for pediatric patients with primary pain complaints.